Get the Stockscreener App
32.42
0.18%
-0.06
After Hours:
32.20
-0.22
-0.68%
ARK Genomic Revolution ETF stock is traded at $32.42, with a volume of 1.93M.
It is down -0.18% in the last 24 hours and up +9.27% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$32.48
Open:
$32.76
24h Volume:
1.93M
Relative Volume:
0.61
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.56%
1M Performance:
+9.27%
6M Performance:
+24.69%
1Y Performance:
+22.06%
1-Day Range:
$32.20
$33.15
1-Week Range:
$31.36
$34.39
52-Week Range:
$17.50
$34.39
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
32.42 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
343.27 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
695.49 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
698.65 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
274.07 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
631.13 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
Cathie Wood's weekly recap: buys WeRide, crypto names, trims defense firm Kratos, PINS, META (ARKK:BATS) - Seeking Alpha
Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops - Benzinga
Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide - TipRanks
Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors - Benzinga
Best Biotech ETFs to Watch Right Now - The Motley Fool
(ARKG) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ARK Invest seeks approval for CoinDesk 20 crypto index ETFs - MSN
Friday's ETF Movers: SLVR, ARKG - Nasdaq
Cathie Wood Sells Beam Therapeutics Stock, Buys WeRide and Tempus AI - Blockonomi
Cathie Wood Sells $5 Million Beam Therapeutics Stock, Buys WeRide and Tempus AI - CoinCentral
Cathie Wood Dumps Over $5M in a Biotech Stock, Buys WeRide and Tempus AI - TipRanks
Ark Invest Boosts Tempus AI Holdings with $925K Purchase Amid 83% Revenue Surge - Intellectia AI
Cathie Wood Loads Up On This Robotaxi Stock, Ark Dumps Roku In Latest Trades - Benzinga
How to Invest in the New Era of Agentic AI for Biotech Stocks - FinancialContent
Cathie Wood Buys Netflix and AI Stocks, Dumps Beam, PINS, and GitLab Shares - TipRanks
Cathie Wood Doubles Down On Netflix Despite Weak Guidance, Ark Invest Dumps This Social Media Stock - Benzinga
Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch - Benzinga
How Rich Is Cathie Wood? What To Know About the Famed Stock Picker and ARK Invest CEO - AOL.com
Intellia Therapeutics Shares Gain as ARK Invest Expands Stake - AD HOC NEWS
Cathie Wood’s ARK Adds to Intellia Stock (NTLA) — Here’s What Else It Traded This Week - TipRanks
Liquidity Mapping Around (ARKG) Price Events - Stock Traders Daily
Cathie Wood Keeps Loading Up on This Biotech Stock — What’s Driving the Buying Spree? - TipRanks
Cathie Wood Sells Meta and Illumina, Loads Up on Early-Stage Genomics Stocks - Blockonomi
Cathie Wood Dumps Meta, Loads Up on Beaten-Down GeneDx Stock - CoinCentral
Cathie Wood Doubles Down on High-Potential Biotech Plays - TipRanks
Nancy Pelosi's Latest Trades Are Heating Up — Tempus AI's 100% Stock Surge Is Leading The Charge - Benzinga
Cathie Wood's weekly recap: tilts to advanced air mobility, sells Meta (ARKK:BATS) - Seeking Alpha
NTLA, PSNL, KMTUY, ILMN: Cathie Wood Buys Early Biotech Stocks, Cuts Stakes in Illumina - TipRanks
BLSH, SLMT, CAI: Cathie Wood loads up on crypto and healthcare stocks, trims a consumer tech name - MSN
How ARK Genomic Revolution ETF stock moves in volatile trading sessionsWeekly Risk Report & Verified Momentum Watchlists - ulpravda.ru
Cathie Wood’s ARK Loads Up on Broadcom, Joby and Archer, Exits Palantir Position - Blockonomi
Cathie Wood Buys Broadcom, Joby, Archer While Selling $10 million Palantir Stock - CoinCentral
Is ARK Genomic Revolution ETF stock worth holding before Fed meetingExit Point & Technical Pattern Alert System - Улправда
Can ARK Genomic Revolution ETF stock reach $200 price target2025 Historical Comparison & Fast Entry Momentum Trade Alerts - Улправда
Thursday's ETF Movers: ITB, ARKG - Nasdaq
Cathie Wood invests millions in Tempus AI and George Soros-backed autonomous firm after major announcement - MSN
Does Tempus AI’s (TEM) Insider Selling Undercut Ark’s Bullish Options-Driven Investment Narrative? - Yahoo Finance
Cathie Wood ARK Buys $13 Million Roblox Stock, Sells Meta Platforms - MEXC
Cathie Wood Invests Millions in Tempus AI and George Soros-Backed Autonomous Firm After Major Announcement - inkl
Cathie Wood Goes Big on Roblox Stock While Dumping Meta Platforms - CoinCentral
RBLX, META, GH, IONS: Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks - TipRanks
Cathie Wood’s ARK Invest Shifts 2026 Strategy, Heavily Bets on Gene Editing Technology - NAI500
TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU - TipRanks
Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify SharesTempus AI (NASDAQ:TEM) - Benzinga
Cathie Wood's moves entering 2026: bets on gene-editing and genomics names, adds BEAM, TWST, NTLA - Seeking Alpha
Cathie Wood Beats S&P 500 in 2025 — This ARK ETF Delivered The Knockout With A 50% Gain - Benzinga
Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — What’s Next for 2026? - TipRanks
Cathie Wood's 2026 Strategy: Betting on Gene Editing, Selling Consumer Technology - 富途牛牛
Cathie Wood's ARK Fintech ETF Bucks 2025 Sector Decline, But Firm's Broader Funds Highlight Persistent Volatility And Losses - Crowdfund Insider
Why (ARKG) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold - TipRanks
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.03%
0.64%
Cap:
|
Volume (24h):